Administration of resveratrol to treat inflammatory respiratory disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Apr 12, 2005
Grant Date -
N/A
app pub date -
Oct 19, 2000
filing date -
Oct 19, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A method is provided for treating inflammatory respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). The method involves administration, preferably oral or pulmonary administration, of an active agent selected from the group consisting of resveratrol, pharmacologically acceptable salts, esters, amides, prodrugs and analogs thereof, and combinations of any of the foregoing. Pharmaceutical formulations for use in conjunction with the aforementioned method are provided as well.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully